...
首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Prognostic factors in patients with idiopathic portal hypertension: Two Japanese nationwide epidemiological surveys in 1999 and 2005
【24h】

Prognostic factors in patients with idiopathic portal hypertension: Two Japanese nationwide epidemiological surveys in 1999 and 2005

机译:特发性门静脉高压症患者的预后因素:1999年和2005年两次日本全国流行病学调查

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aim: To investigate factors affecting disease prognosis among patients with idiopathic portal hypertension (IPH). Methods: Two Japanese nationwide epidemiological surveys on IPH were conducted in 1999 and 2005. Analyzing data from each cross-sectional survey separately, we examined the consistent prognostic factors detected from each analysis and assessed the effect of treatments for varices on IPH prognosis. Outcome was the disease condition at last observation compared with that at diagnosis, categorized into two levels (recovered/improved and unchanged/aggravated/deceased). To evaluate the association with each characteristic, we calculated adjusted odds ratio (OR) and 95% confidence interval (CI) using a binary model for logistic regression. Results: Among 160 patients with IPH in 1999 and 85 in 2005, 10% had aggravated disease at a mean of 6-7years after the diagnosis. Statistically significant ORs were observed for two factors: esophageal varices, especially of F2-3 stage, at diagnosis (OR=6.83, 95% CI=2.10-22.1 in 1999; OR=10.7, 95% CI=1.08-105 in 2005) ameliorated IPH; and hepatic encephalopathy at diagnosis (OR=0.19, 95% CI=0.03-1.04 in 1999; crude OR=0.05, 95% CI=0.01-0.60 in 2005 using a proportional odds model) worsened IPH. Further analyses explained that the apparent ameliorating effect of esophageal varices was due to the effect of subsequent treatment (OR=4.59, 95% CI=0.89-23.7 in 2005). Conclusion: The prognosis of IPH would be better if varices were adequately controlled. Patients with liver failure at diagnosis would be at high risk for subsequent disease aggravation.
机译:目的:探讨影响特发性门静脉高压症(IPH)患者疾病预后的因素。方法:在1999年和2005年进行了两次日本全国IPH流行病学调查。分别分析每个横断面调查的数据,我们检查了每次分析中发现的一致的预后因素,并评估了静脉曲张治疗对IPH预后的影响。结果是最后一次观察的疾病状况与诊断时的状况相比较,分为两个级别(恢复/改善和不变/加重/死亡)。为了评估与每个特征的关联,我们使用二元模型进行逻辑回归计算了调整后的优势比(OR)和95%置信区间(CI)。结果:1999年的160例IPH患者和2005年的85例患者中,有10%的病情在诊断后的6-7年内平均加重。在两个因素上观察到统计学上显着的OR:在诊断时食管静脉曲张,尤其是F2-3期(OR = 6.83,95%CI = 2.10-22.1,1999年; OR = 10.7,95%CI = 1.08-105)。改善IPH;和诊断时的肝性脑病(1999年OR = 0.19,95%CI = 0.03-1.04; 2005年粗OR = 0.05,95%CI = 0.01-0.60)使用IPH恶化。进一步的分析表明,食管静脉曲张的明显改善作用是由于后续治疗的影响(2005年OR = 4.59,95%CI = 0.89-23.7)。结论:如果适当控制静脉曲张,IPH的预后将更好。诊断为肝功能衰竭的患者随后患病的风险较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号